Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-19-005715
Filing Date
2019-05-24
Accepted
2019-05-24 17:35:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 50362
2 GRAPHIC g730455g0523052622291.jpg GRAPHIC 2406
  Complete submission text file 0000950123-19-005715.txt   54717
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

EIN.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations